Major Themes
|
n
|
% of Total
|
% of Theme
|
Mention of other substances |
707 |
20.6 |
100 |
Effects of THC-O-acetate |
522 |
15.2 |
100 |
Comments on specific brands/products |
517 |
15.0 |
100 |
Discussion of THC-O-acetate use (Frequency, Administration methods, Preparation methods) |
485 |
14.1 |
100 |
Comparisons with other substances |
434 |
12.6 |
100 |
Concerns |
333 |
9.7 |
100 |
Discussion of chemical/physiological mechanisms |
162 |
4.7 |
100 |
Adverse Experiences |
136 |
4.0 |
100 |
Discussion of THC-O-acetate production (how THC-O-acetate) is manufactured |
99 |
2.9 |
100 |
Reasons for THC-O-acetate use |
34 |
1.0 |
100 |
Themes with elaboration
|
n
|
% of Total
|
% of Theme
|
Mention of other substances
|
707
|
20.6
|
100
|
Mention of delta-8-THC |
387 |
11.3 |
54.7 |
Mention of delta-9-THC |
288 |
8.4 |
40.7 |
Mention of Psychedelics (LSD, DMT, Psilocybin) |
32 |
0.9 |
4.5 |
Mention of other substances |
258 |
7.5 |
36.5 |
Effects of THC-O-acetate
|
522
|
15.2
|
100
|
Lack of any effects |
95 |
2.8 |
18.2 |
’Standard‘ THC experiences |
92 |
2.7 |
17.6 |
Lengthy onset |
53 |
1.5 |
10.2 |
Psychedelic/spiritual experience |
48 |
1.4 |
9.2 |
Lengthy duration |
39 |
1.1 |
7.5 |
Sedating/calming |
37 |
1.1 |
7.1 |
Lack of psychedelic effects (but other effects present) |
30 |
0.9 |
5.7 |
Psychedelic hallucinations (visuals, hearing sounds, etc.) |
25 |
0.7 |
4.8 |
Physical/body sensation |
20 |
0.6 |
3.8 |
Decreased effects from tolerance |
19 |
0.6 |
3.6 |
Euphoria |
16 |
0.5 |
3.1 |
Medically beneficial for pain relief |
11 |
0.3 |
2.1 |
Energizing |
9 |
0.3 |
1.7 |
Cross-tolerance between cannabinoids |
4 |
0.1 |
0.8 |
Weird dreams |
4 |
0.1 |
0.8 |
Increased sexual arousal |
4 |
0.1 |
0.8 |
Lots of laughing |
4 |
0.1 |
0.8 |
No changes in effects from tolerance reported |
3 |
0.1 |
0.6 |
Feeling drunk |
2 |
0.1 |
0.4 |
Improved sleep |
2 |
0.1 |
0.4 |
Disrupted sleep |
2 |
0.1 |
0.4 |
Comparisons with other substances
|
434
|
12.6
|
100
|
Comparison with delta-9-THC |
241 |
7.0 |
55.5 |
Comparison with delta-8-THC |
235 |
6.8 |
54.1 |
Comparison with Psychedelics (LSD, DMT, Psilocybin) |
46 |
1.3 |
10.6 |
Comparison with other substances |
90 |
2.3 |
20.7 |
Concerns
|
333
|
9.7
|
100
|
Variation in product composition or effect |
63 |
1.8 |
18.0 |
Health |
60 |
1.7 |
17.1 |
Safety concerns from novelty of product, lack of research |
57 |
1.7 |
14.1 |
Legality |
47 |
1.4 |
12.9 |
Safety |
43 |
1.3 |
8.1 |
Inconsistencies in product quality |
27 |
0.8 |
5.7 |
Safety concerns from impurities |
19 |
0.6 |
4.2 |
Shelf life/stability |
14 |
0.4 |
2.4 |
Ketene risk |
8 |
0.2 |
2.1 |
Smell |
7 |
0.2 |
1.8 |
Building tolerance |
6 |
0.2 |
1.2 |
Variation in metabolism/effect |
4 |
0.1 |
1.2 |
Accessibility |
4 |
0.1 |
1.2 |
Concerns with specific brands |
4 |
0.1 |
18.0 |
Adverse experiences
|
136
|
4.0
|
100
|
Physical adverse experience (e.g., coughing) |
91 |
2.6 |
66.9 |
Anxiety |
14 |
0.4 |
10.3 |
Pain |
12 |
0.3 |
8.8 |
Bad trip/unpleasant experience |
9 |
0.3 |
6.6 |
Bad taste |
6 |
0.2 |
4.4 |
Overconsumption from effect latency |
3 |
0.1 |
2.2 |
Unpleasant after-effects |
3 |
0.1 |
2.2 |
Poor sleep quality |
2 |
0.1 |
1.5 |
Feeling “drunk” |
2 |
0.1 |
1.5 |
Reasons for THC-O-acetate use
|
34
|
1.0
|
100
|
Medical - Pain |
8 |
0.2 |
23.5 |
Unspecified Medical/Therapeutic |
6 |
0.2 |
17.6 |
Medical - Insomnia/Sleep issues |
5 |
0.1 |
14.7 |
Medical - Anxiety |
3 |
0.1 |
8.8 |
Substitution for synthetic cannabinoids |
3 |
0.1 |
8.8 |
Recreational |
2 |
0.1 |
5.9 |
Medical - Arthritis |
1 |
0 |
2.9 |